JP2023511125A5 - - Google Patents
Info
- Publication number
- JP2023511125A5 JP2023511125A5 JP2022544076A JP2022544076A JP2023511125A5 JP 2023511125 A5 JP2023511125 A5 JP 2023511125A5 JP 2022544076 A JP2022544076 A JP 2022544076A JP 2022544076 A JP2022544076 A JP 2022544076A JP 2023511125 A5 JP2023511125 A5 JP 2023511125A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant polypeptide
- polypeptide according
- cov
- sars
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062965033P | 2020-01-23 | 2020-01-23 | |
| US62/965,033 | 2020-01-23 | ||
| US202063050473P | 2020-07-10 | 2020-07-10 | |
| US63/050,473 | 2020-07-10 | ||
| PCT/US2021/014818 WO2021151043A2 (en) | 2020-01-23 | 2021-01-23 | Methods and compositions for treating and preventing viral infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511125A JP2023511125A (ja) | 2023-03-16 |
| JP2023511125A5 true JP2023511125A5 (https=) | 2024-01-31 |
Family
ID=76991836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544076A Pending JP2023511125A (ja) | 2020-01-23 | 2021-01-23 | ウイルス感染を治療及び予防するための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240002452A1 (https=) |
| EP (1) | EP4093758A4 (https=) |
| JP (1) | JP2023511125A (https=) |
| KR (1) | KR20220136369A (https=) |
| CN (1) | CN115943154A (https=) |
| AU (1) | AU2021210993A1 (https=) |
| BR (1) | BR112022014552A2 (https=) |
| CA (1) | CA3165586A1 (https=) |
| WO (1) | WO2021151043A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11518788B2 (en) | 2020-07-10 | 2022-12-06 | Avirus, Inc. | Methods and compositions for treating and preventing viral infection |
| EP4147702A1 (en) * | 2021-09-13 | 2023-03-15 | Medizinische Universität Graz | Novel combination of heparin and ace2 decoys for the treatment of covid-19 |
| WO2023081958A1 (en) * | 2021-11-11 | 2023-05-19 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | Antiviral agent comprising a cellular entry receptor and fc region component |
| CN114989269B (zh) * | 2022-06-30 | 2023-09-19 | 天康制药股份有限公司 | 一种牛赤羽免疫原性抗原及疫苗 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6297048B1 (en) * | 1992-02-04 | 2001-10-02 | Chiron Corporation | Hepatitis therapeutics |
| AU3448899A (en) * | 1998-01-24 | 1999-08-09 | Bristol-Myers Squibb Company | Artificial proteoglycans |
| AU7070700A (en) * | 1999-08-25 | 2001-03-19 | Massachusetts Institute Of Technology | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
| US6511832B1 (en) * | 1999-10-06 | 2003-01-28 | Texas A&M University System | In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase |
| US7671018B2 (en) * | 2000-08-30 | 2010-03-02 | University Of Delaware | Delivery system for heparin-binding growth factors |
| AT505262A1 (de) * | 2007-06-12 | 2008-12-15 | Apeiron Biolog Forschungs Und | Rekombinantes ace2 polypeptid |
| WO2018140456A1 (en) * | 2017-01-24 | 2018-08-02 | Northwestern University | Active low molecular weight variants of angiotensin converting enzyme 2 (ace2) |
| US11518788B2 (en) * | 2020-07-10 | 2022-12-06 | Avirus, Inc. | Methods and compositions for treating and preventing viral infection |
-
2021
- 2021-01-23 KR KR1020227027998A patent/KR20220136369A/ko active Pending
- 2021-01-23 WO PCT/US2021/014818 patent/WO2021151043A2/en not_active Ceased
- 2021-01-23 CN CN202180010808.6A patent/CN115943154A/zh active Pending
- 2021-01-23 CA CA3165586A patent/CA3165586A1/en active Pending
- 2021-01-23 JP JP2022544076A patent/JP2023511125A/ja active Pending
- 2021-01-23 BR BR112022014552A patent/BR112022014552A2/pt not_active IP Right Cessation
- 2021-01-23 AU AU2021210993A patent/AU2021210993A1/en not_active Abandoned
- 2021-01-23 EP EP21744864.6A patent/EP4093758A4/en not_active Withdrawn
-
2022
- 2022-10-17 US US18/047,150 patent/US20240002452A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511125A5 (https=) | ||
| Fröhlich et al. | Oral inhalation for delivery of proteins and peptides to the lungs | |
| JP2023518038A5 (https=) | ||
| JP2009537143A5 (https=) | ||
| WO2021159648A1 (zh) | 一种β冠状病毒抗原、其制备方法和应用 | |
| JP2008512117A5 (https=) | ||
| JP2015512876A5 (https=) | ||
| EP4138998A2 (en) | Compositions and methods for preventing or reducing the effects of infections by coronaviruses that bind the ace2 receptor | |
| KR20160011621A (ko) | 재조합 인간 분비글로빈에 대한 개선된 사용 방법 | |
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| JP2023542453A5 (https=) | ||
| US12539328B2 (en) | Oral vaccine via dental bacteria and emitted peptides to prevent COVID-19 infection | |
| WO2021198395A1 (en) | Surfactant protein d for use in treating coronavirus infections | |
| KR20060041163A (ko) | 코로나바이러스에 의한 감염을 치료, 조절 및 예방하기위한 항바이러스 제제들 | |
| CN112020369A (zh) | 病毒治疗 | |
| CN111163792A (zh) | 用于治疗病毒感染的肽 | |
| EA014352B1 (ru) | Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента | |
| CN116063468A (zh) | 中和呼吸道合胞病毒的c-型单域抗体及应用 | |
| JP2023534987A5 (https=) | ||
| US20230165943A1 (en) | Tp508 acute therapy for patients with respiratory virus infection | |
| Alabdali et al. | Impact of covid-19 on multiple body organ failure: a review | |
| WO2024229151A2 (en) | Multimeric coronavirus binding molecules and uses thereof | |
| EP4147702A1 (en) | Novel combination of heparin and ace2 decoys for the treatment of covid-19 | |
| JP5396111B2 (ja) | インフルエンザ治療／予防薬 | |
| JPWO2023190199A5 (https=) |